Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Alberti

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Journal of Hepatology|November 21, 1998
HGV/GBV-C infection in liver transplant recipients: antibodies to the viral E2 envelope glycoprotein protect from de novo infectionE Silini, L Belli, A B Alberti, et al.
Hepatology (Baltimore, Md.)|May 29, 2000
Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantationL S Belli, C Zavaglia, A B Alberti, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2010
The maximum tolerated dose and biologic effects of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumorsBrian S Choi, Dona B Alberti, William R Schelman, et al.
Investigational New Drugs|July 18, 2013
A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancerWilliam R Schelman, Tabraiz A Mohammed, Anne M Traynor, et al.
Journal of Inorganic Biochemistry|December 7, 2007
Electron paramagnetic resonance study of peripheral blood mononuclear cells from patients with refractory solid tumors treated with TriapineJill M Kolesar, William R Schelman, Peter G Geiger, et al.
Cancer Research|May 1, 1990
Phase I trial of 5-fluorouracil and dipyridamole administered by seventy-two-hour concurrent continuous infusionS C Remick, J L Grem, P H Fischer, et al.
Cancer Research|November 15, 1989
Phase I trial of hepatic artery infusion of 5-iodo-2'-deoxyuridine and 5-fluorouracil in patients with advanced hepatic malignancy: biochemically based combination chemotherapyS C Remick, A B Benson, J L Weese, et al.
Experimental and Therapeutic Medicine|March 5, 2011
Cytotoxic Evaluation of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone, 3-AP, in Peripheral Blood Lymphocytes of Patients with Refractory Solid Tumors using Electron Paramagnetic ResonanceJill M Kolesar, Kamakshi Sachidanandam, William R Schelman, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitorsKirk L Stevens, Michael J Reno, Jennifer B Alberti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 20, 2012
Antiviral therapy and fibrosis progression in patients with mild-moderate hepatitis C recurrence after liver transplantation. A randomized controlled studyLuca S Belli, Riccardo Volpes, Ivo Graziadei, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of Hepatology|November 21, 1998
HGV/GBV-C infection in liver transplant recipients: antibodies to the viral E2 envelope glycoprotein protect from de novo infectionE Silini, L Belli, A B Alberti, et al.
Hepatology (Baltimore, Md.)|May 29, 2000
Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantationL S Belli, C Zavaglia, A B Alberti, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2010
The maximum tolerated dose and biologic effects of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumorsBrian S Choi, Dona B Alberti, William R Schelman, et al.
Investigational New Drugs|July 18, 2013
A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancerWilliam R Schelman, Tabraiz A Mohammed, Anne M Traynor, et al.
Journal of Inorganic Biochemistry|December 7, 2007
Electron paramagnetic resonance study of peripheral blood mononuclear cells from patients with refractory solid tumors treated with TriapineJill M Kolesar, William R Schelman, Peter G Geiger, et al.
Cancer Research|May 1, 1990
Phase I trial of 5-fluorouracil and dipyridamole administered by seventy-two-hour concurrent continuous infusionS C Remick, J L Grem, P H Fischer, et al.
Cancer Research|November 15, 1989
Phase I trial of hepatic artery infusion of 5-iodo-2'-deoxyuridine and 5-fluorouracil in patients with advanced hepatic malignancy: biochemically based combination chemotherapyS C Remick, A B Benson, J L Weese, et al.
Experimental and Therapeutic Medicine|March 5, 2011
Cytotoxic Evaluation of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone, 3-AP, in Peripheral Blood Lymphocytes of Patients with Refractory Solid Tumors using Electron Paramagnetic ResonanceJill M Kolesar, Kamakshi Sachidanandam, William R Schelman, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitorsKirk L Stevens, Michael J Reno, Jennifer B Alberti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 20, 2012
Antiviral therapy and fibrosis progression in patients with mild-moderate hepatitis C recurrence after liver transplantation. A randomized controlled studyLuca S Belli, Riccardo Volpes, Ivo Graziadei, et al.
Pageof 5